Retail investors are strongly supporting Cosmos Holdings Inc. (NASDAQ: COSM) at the moment. Otcstockz took the decision to do a detailed analysis of COSM Stock.
Latest update on COSM Stock Cosmos Holdings Inc. (NASDAQ: COSM)
Grigorios Siokas, Chief Executive Officer at Cosmos Holdings reported a large insider buy on November 28, according to a new SEC filing. A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Siokas purchased 801,261 shares of Cosmos Holdings. The total transaction amounted to $497,983.
Detail Analysis on COSM Stock
Since reversing off $0.0675 lows earlier this month, Cosmos Holdings Inc (NASDAQ: COSM) has shot up the charts in the north direction, recently surpassing $0.83 per share, with speculators pointing at $1 as the next target.
COSM was trading well over $3 at the start of this year, but since then, it has been severely shorted, with current estimates placing the number of shares sold short at well over 5 million, or nearly the entire float.
Although COSM has been extensively shorted into oblivion, the company has lately reported revenues of $12 million for the three months ended September 30. The business of the company is effectively growing, and they just signed a contract for the inflight distribution of their goods with the European airline Iberica. The CEO has purchased millions of shares at the present price, and COSM is starting to get traction on social media, trending on the reddit subreddit Short Squeeze, ranking #1 on Stocktwits, and the subject of numerous YouTube videos about a significant short squeeze in small caps.
YouTube sentiments on COSM Stock
Social media is buzzing with talk of one such YouTube video that has received 12k views in just twelve hours. “The short squeeze that will be bigger than AMC/GME combined” was the title given to the video.
In the past 12 hours, one more YouTube video has accumulated 5K views. “Will COSM STOCK hit multiple dollars per share”?
Sentiments in Twitter on COSM Stock
One well-known trader BMoe with approximately 44K followers announced a giveaway tweet if COSM stock reached $5; at the time of this writing, the tweet had 488 likes and 629 retweets.
https://twitter.com/BMoeBlessed/status/1595159038081511427?s=20&t=BOVXX8p8WYWmYZARyw-Iyg
At the time of writing, a number of well-known traders with sizable twitter followings are urging COSM Stock to see greater momentum. Below are a few of the tweets.
https://twitter.com/AvidTrader_/status/1597350067140440064?s=20&t=BOVXX8p8WYWmYZARyw-Iyg
https://twitter.com/MoonMarket_/status/1597621327653109766?s=20&t=BOVXX8p8WYWmYZARyw-Iyg
$COSM Seems about right… .75 then $1… and it can all be done sooner than you think. They can continue fighting the move… won't last.
— EC MONEY 💰 (@ecgreendays) November 29, 2022
No pump, just stating what i see. https://t.co/VLW6PJIbtK pic.twitter.com/jwxPoCzHS2
Reddit sentiments on COSM Stock
Why this play is good, nimble broccoli responded on the subreddit ShortSqueeze
1.) Extremely tiny Marketcap
2.) CEO buying 15’000’000 shares
3.) Good fundamentals, unlike other plays, they actually sell products valued around 10x the valuation. Q1/22 was profitable.
4.) Getting momentum on social media (Reddit Twitter, YT)
About COSM Stock
Cosmos Holdings Inc(NASDAQ: COSM) is a global healthcare group that was incorporated in 2009 and is headquartered in Chicago, Illinois. Cosmos Health is engaged in the nutraceuticals sector through its own proprietary lines of products “Sky Premium Life” and “Mediterranation.” Additionally, the Company is operating in the pharmaceutical sector through the provision of a broad line of branded generics and OTC medications and is involved in the healthcare distribution sector through its subsidiaries in Greece and UK serving retail pharmacies and wholesale distributors. Cosmos Health is strategically focused on the R&D of novel patented nutraceuticals (IP) and specialized root extracts as well as on the R&D of proprietary complex generics and innovative OTC products. Cosmos has developed a global distribution platform and is currently expanding throughout Europe, Asia and North America. Cosmos Health has offices and distribution centers in Thessaloniki and Athens, Greece and Harlow, UK.
By supplying name-brand and generic medications, over-the-counter medications, vitamins, and nutraceuticals to the region of Greece’s 1,500 independent retail pharmacies and 40 pharmaceutical wholesalers, Cosmos conducts business in the full-line pharmaceutical wholesale distribution industry. Cosmos makes technology investments to increase dependability, efficiency, and safety in distribution and warehousing. In order to guarantee 0% error selection rate, expedite order fulfillment, and increase cost-efficiency in our distribution center, the Company specifically operates a fully automated warehouse system with three robotic systems, two ROWATM kinds, and one A-frame type. Three of Cosmos’ operating subsidiaries are as follows:
Sky Pharm SA
The headquarters of Sky Pharm SA are in Thessaloniki, Greece. About 500 pharmaceuticals that are allowed for export within the EU are traded by Sky Pharm in excess quantities. We import medicines from Greek multinational pharmaceutical producers and wholesalers and sell them in European markets where demand and pricing are much greater.
Decahedron Ltd.
A pharmaceutical wholesaler named Decahedron Ltd. was established in the UK in August 2011. The MHRA conducts an audit of it under European GDP (Good Distribution Practices). They have also been audited by TÜV on their behalf and are full members of the EAEPC.
COSMOFARM
Pharmaceutical wholesaler Cosmofarm was established in 1994 and serves the greater Athens area. The National Organization for Medicines has granted the business approval and authorization to distribute a wide variety of pharmaceutical items in accordance with Good Distribution Practices. The main activities of Cosmofarm are brand sourcing, acquisition, and distribution.
The COSM business is doing well, and Q3 highlights included closing a $7.5 million capital raise through a public offering and signing an exclusive agreement to market and distribute Nickelodeon’s SpongeBob and PAW Patrol kids’ vitamins in Greece and Cyprus. The company aims to reach 11,000 pharmacies and 120 wholesalers in Greece and 780 pharmacies in Cyprus with this distribution. Additionally, they signed a letter of intent for a joint venture to cross-market goods and services in their respective markets with Smart for Life (SMLF).
Additionally, COSM signed a LOI to purchase ZipDoctor Inc. and a contract with Virax Biolabs (VRAX) to distribute Monkeypox Virus Real-Time PCR Detection Kits. COSM will have exclusive distribution rights for Greece and Cyprus and the option to non-exclusively distribute the test kits throughout Europe. On Amazon in the US, SkyPharm formally unveiled its first Sky Premium Life products. By the end of the year, Cosmos hopes to have all 85 SKUs available on Amazon. Pharmaceutical Laboratories CANA S.A. and the product portfolio of LIFE NLB, Ltd., which includes the bone health supplements Bone-Vio® and Bone-X and targets the human gastrointestinal microbiome, were the targets of a LOI entered into by COSM.
On November 21, COSM stated that Ronda, the official inflight magazine of the airline operator Iberia of the BRITISH AIRWAYS group, will begin selling its Sky Premium Life luxury food supplement brand. Iberian Airlines’ more than 10 million customers can use Ronda without paying anything at all. Over 600 flights are operated daily by Iberia Airlines, which is majority owned by British Airways. On all Iberia flights, the magazine is available digitally via the onboard screens and has an interactive QR Code for ordering on the intranet. Iberia Plus, Platinum, and Gold level members as well as Executives Plus and Frequent Flyer Premium members are also sent the magazine. With 72% of Ronda’s readers holding advanced degrees and 81% being over the age of 35, they have considerable purchasing power. A proprietary brand of premium nutritional supplements, Sky Premium Life offers a full selection of vitamins, minerals, herbs, and special formulae.
COSM, which is currently valued at $36 million on the market, is the most recent prospective target of a short squeeze that investors are keeping a close eye on. Even though the Company’s business has been doing well, COSM stock has lagged due to the Company’s $36 million in current liabilities and its failure to collect on accounts receivables, which currently stand at over $25 million. CEO purchased millions of shares at the current price, and COSM is starting to gain traction on social media, ranking as the top stock on Stock Twits, and the topic of numerous YouTube videos about a significant short squeeze occurring in small caps.
Make sure you are a subscriber to otcstockz since we will update on COSM as new information becomes available.
Disclosure: We disclose that we do not own any shares of COSM, either long or short, and that we have not received any payment for this article.
